Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice
Published inJournal of controlled release, vol. 144, no. 3, p. 324-331
Publication date2010
Abstract
Keywords
- Animals
- Antibodies, Monoclonal/administration & dosage/pharmacokinetics/*therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Phytogenic/administration & dosage/pharmacokinetics/*therapeutic use
- Cell Line, Tumor
- Drug Carriers/*chemistry
- Female
- Humans
- Mice
- Nanoparticles/*chemistry
- Ovarian Neoplasms/*drug therapy
- Paclitaxel/administration & dosage/pharmacokinetics/*therapeutic use
- Receptor, erbB-2/*immunology
- Tissue Distribution
- Xenograft Model Antitumor Assays
Citation (ISO format)
CIRSTOIU, Adriana et al. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. In: Journal of controlled release, 2010, vol. 144, n° 3, p. 324–331. doi: 10.1016/j.jconrel.2010.02.026
Main files (1)
Article
Identifiers
- PID : unige:20850
- DOI : 10.1016/j.jconrel.2010.02.026
- PMID : 20219607
Journal ISSN0168-3659